Drug Chatter -- Tracking biopharma stock chatter

Profile for Intra-Cellular Therapies Inc. (ITCI)

« Back to company index

ITCI Chatter Timeline

Stock Ticker for ITCI

Most Active Tweeters for ITCI

UserTweets
@TickerReport 4
@WatchlistN 3
@intercooleronli 3
@CFinancialNews 3
@dakotafinancial 3

Recent Tweets for ITCI

dredaicnc @dredaicnc
$itci should work on CTE medication
September 25th 2017, 4:09pm
noritsunagirota @noritsunagirota
46.76% to Target, Cantor Fitzgerald Maintains Buy Rating for Intra-Cellular Therapies $ITCI Stock ...
September 25th 2017, 3:09pm
SleekMoneycom @SleekMoneycom
Intra-Cellular Therapies Inc. $ITCI Earns “Buy” Rating from BTIG Research https://t.co/w81zbVjiGe
September 24th 2017, 5:09am
intercooleronli @intercooleronli
Intra-Cellular Therapies Inc. $ITCI Given Consensus Recommendation of “Buy” by Analysts https://t.co/lvyOVewcp7
September 23rd 2017, 8:09pm
WatchlistN @WatchlistN
Intra-Cellular Therapies Inc. $ITCI Given Consensus Recommendation of “Buy” by Analysts https://t.co/V4oGDgJn01
September 23rd 2017, 8:09pm
CFinancialNews @CFinancialNews
Intra-Cellular Therapies Inc. $ITCI Given Consensus Recommendation of “Buy” by Analysts https://t.co/MjLLLV5Cb8
September 23rd 2017, 8:09pm
SleekMoneycom @SleekMoneycom
Intra-Cellular Therapies Inc. $ITCI Rating Increased to Overweight at Piper Jaffray Companies https://t.co/dJKROAT5fg
September 23rd 2017, 7:09am
chaffeybreeze @chaffeybreeze
Intra-Cellular Therapies $ITCI and Agile Therapeutics $AGRX Head-To-Head Comparison https://t.co/YO3etu3hVl
September 23rd 2017, 2:09am
IRAMarketReport @IRAMarketReport
Intra-Cellular Therapies $ITCI and Agile Therapeutics $AGRX Head-To-Head Comparison https://t.co/LJEdBcs43k
September 23rd 2017, 2:09am
WatchlistN @WatchlistN
Intra-Cellular Therapies Inc. $ITCI Shares Bought by BB Biotech AG https://t.co/f0BgFNeDmv
September 22nd 2017, 12:09pm
paglethrive @paglethrive
@adamfeuerstein What are your current thoughts on $ITCI? Very positive developments. Surprised it has not rallied substantially more IMO
September 22nd 2017, 11:09am
dakotafinancial @dakotafinancial
60,720 Shares in Intra-Cellular Therapies Inc. $ITCI Acquired by Los Angeles Capital Management & Equity Research … https://t.co/yXgQaM08t9
September 22nd 2017, 6:09am
intercooleronli @intercooleronli
Analyzing Agile Therapeutics $AGRX and Intra-Cellular Therapies $ITCI https://t.co/p6aPg8hZmN
September 20th 2017, 6:09pm
TickerReport @TickerReport
Analyzing Agile Therapeutics $AGRX and Intra-Cellular Therapies $ITCI https://t.co/pV9yDxISII
September 20th 2017, 6:09pm
TickerReport @TickerReport
Analyzing Agile Therapeutics $AGRX and Intra-Cellular Therapies $ITCI https://t.co/ulSnljImNS
September 20th 2017, 6:09pm
CFinancialNews @CFinancialNews
Analyzing Agile Therapeutics $AGRX and Intra-Cellular Therapies $ITCI https://t.co/tyQcGlABK4
September 20th 2017, 6:09pm
emq_news @emq_news
Analyzing Agile Therapeutics $AGRX and Intra-Cellular Therapies $ITCI https://t.co/VUSDBrUGJJ
September 20th 2017, 6:09pm
TickerReport @TickerReport
Intra-Cellular Therapies $ITCI – Analysts’ Recent Ratings Changes https://t.co/hL5r5GNs6S
September 19th 2017, 9:09am
emq_news @emq_news
Intra-Cellular Therapies $ITCI – Analysts’ Recent Ratings Changes https://t.co/4fbATx2t88
September 19th 2017, 9:09am
TickerReport @TickerReport
Intra-Cellular Therapies $ITCI – Analysts’ Recent Ratings Changes https://t.co/Mwjc2usb78
September 19th 2017, 9:09am
intercooleronli @intercooleronli
Intra-Cellular Therapies $ITCI – Analysts’ Recent Ratings Changes https://t.co/2ZWrtL3C2Y
September 19th 2017, 7:09am
CFinancialNews @CFinancialNews
Intra-Cellular Therapies $ITCI – Analysts’ Recent Ratings Changes https://t.co/NTxLeroMVH
September 19th 2017, 7:09am
will_trade4food @will_trade4food
$ITCI bullish reversal off 9EMA https://t.co/qNImXvGx2t
September 18th 2017, 6:09pm
szaman @szaman
$ITCI doing its thing.
September 18th 2017, 9:09am
GNWLive @GNWLive
Intra-Cellular Therapies to Participate at Upcoming Investor Conferences $ITCI https://t.co/IFMMPGFNzR
September 18th 2017, 8:09am
stocknewstimes @stocknewstimes
Intra-Cellular Therapies Inc. $ITCI Rating Reiterated by Cowen and Company https://t.co/MSMvXlZ4Gf
September 16th 2017, 4:09pm
WeekHerald @WeekHerald
Comparing Intra-Cellular Therapies $ITCI and Regenxbio $RGNX https://t.co/mPeKYIJuqK
September 16th 2017, 12:09am
SleekMoneycom @SleekMoneycom
Intra-Cellular Therapies Inc. $ITCI Upgraded to Overweight at Piper Jaffray Companies https://t.co/dJKROAT5fg
September 15th 2017, 3:09pm
stocknewstimes @stocknewstimes
Head-To-Head Contrast: Regenxbio $RGNX vs. Intra-Cellular Therapies $ITCI https://t.co/a7bARvtU0G
September 15th 2017, 1:09pm
chaffeybreeze @chaffeybreeze
Research Analysts Issue Forecasts for Intra-Cellular Therapies Inc.’s FY2018 Earnings $ITCI https://t.co/v9BRCGvffi
September 13th 2017, 2:09pm
IRAMarketReport @IRAMarketReport
Research Analysts Issue Forecasts for Intra-Cellular Therapies Inc.’s FY2018 Earnings $ITCI https://t.co/61URs5YIeN
September 13th 2017, 2:09pm
bnbdailynews @bnbdailynews
Critical Comparison: Intra-Cellular Therapies $ITCI and REGENXBIO $RGNX https://t.co/yCFgqI2iug
September 13th 2017, 8:09am
SPNewsAnalysis @SPNewsAnalysis
FY2018 Earnings Estimate for Intra-Cellular Therapies Inc. Issued By SunTrust Banks $ITCI https://t.co/P2ZjET9w0U
September 12th 2017, 3:09pm
storminvestor @storminvestor
FY2018 Earnings Estimate for Intra-Cellular Therapies Inc. Issued By SunTrust Banks $ITCI https://t.co/fNBOzRhxgF
September 12th 2017, 2:09pm
dakotafinancial @dakotafinancial
Intra-Cellular Therapies’ $ITCI “Hold” Rating Reiterated at SunTrust Banks, Inc. https://t.co/PwisuNCfUp
September 12th 2017, 7:09am
ConsumerFeed @ConsumerFeed
Intra-Cellular Therapies’ $ITCI “Hold” Rating Reiterated at SunTrust Banks, Inc. https://t.co/taAqU8x10b
September 12th 2017, 7:09am
WatchlistN @WatchlistN
Intra-Cellular Therapies Inc. $ITCI Given Buy Rating at BTIG Research https://t.co/PiUT7hwqT2
September 12th 2017, 7:09am
midetimes @midetimes
Intra-Cellular Therapies Inc. $ITCI Stock Rating Reaffirmed by Cowen and Company https://t.co/YBHFqPmWd6
September 12th 2017, 4:09am
dailypoliticaln @dailypoliticaln
Intra-Cellular Therapies Inc. $ITCI Stock Rating Reaffirmed by Cowen and Company https://t.co/LM6gOSxz0v
September 12th 2017, 4:09am
WKRBNews @WKRBNews
Intra-Cellular Therapies Inc. $ITCI Stock Rating Reaffirmed by Cowen and Company https://t.co/VjxUcNJdr3
September 12th 2017, 4:09am
dailymailtimes @dailymailtimes
Intra-Cellular Therapies Inc. $ITCI Stock Rating Reaffirmed by Cowen and Company https://t.co/Pz4bZ3Vksw
September 12th 2017, 4:09am
ConsumerFeed @ConsumerFeed
Intra-Cellular Therapies $ITCI Getting Positive Press Coverage, Report Finds https://t.co/7zY74dGuWc
September 12th 2017, 4:09am
dakotafinancial @dakotafinancial
Intra-Cellular Therapies $ITCI Getting Positive Press Coverage, Report Finds https://t.co/AybBjfN33X
September 12th 2017, 4:09am
AmericanBanking @AmericanBanking
SunTrust Banks Equities Analysts Cut Earnings Estimates for Intra-Cellular Therapies Inc. $ITCI https://t.co/hV5bJcQTCN
September 11th 2017, 9:09am
CFinancialNews @CFinancialNews
SunTrust Banks Equities Analysts Cut Earnings Estimates for Intra-Cellular Therapies Inc. $ITCI https://t.co/Yjew0se5m8
September 11th 2017, 9:09am
intercooleronli @intercooleronli
SunTrust Banks Equities Analysts Cut Earnings Estimates for Intra-Cellular Therapies Inc. $ITCI https://t.co/deBQyaP0dV
September 11th 2017, 9:09am
midetimes @midetimes
Intra-Cellular Therapies Inc. $ITCI Upgraded by Piper Jaffray Companies to “Overweight” https://t.co/oPyNAoyUJJ
September 11th 2017, 9:09am
WKRBNews @WKRBNews
Intra-Cellular Therapies Inc. $ITCI Upgraded by Piper Jaffray Companies to “Overweight” https://t.co/5FvDdAhJfd
September 11th 2017, 9:09am
dailypoliticaln @dailypoliticaln
Intra-Cellular Therapies Inc. $ITCI Upgraded by Piper Jaffray Companies to “Overweight” https://t.co/0usDldPWlC
September 11th 2017, 9:09am
dailymailtimes @dailymailtimes
Intra-Cellular Therapies Inc. $ITCI Upgraded by Piper Jaffray Companies to “Overweight” https://t.co/ULdKRRgnYd
September 11th 2017, 9:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.